Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting. by Suman Rao, Anne-Laure Larroque-Lombard, Lisa Peyrard, Cédric Thauvin, Zakaria Rachid, Christopher Williams, Bertrand J Jean-Claude

Get full text